Homepage Jan 2023

Join the Psychedelic Renaissance

Together, we can create a post-prohibition reality where psychedelic healing is available to all who can benefit from it. 

GET INVOLVED

Join our Mission to Bring Psychedelic Healing to All

MAPS frequently shares information on the latest science, research, events, and opportunities for action in the ever expanding world of Psychedelics

Our Work

MAPS is a nonprofit organization that provides public resources and leadership as we work together to create legal, responsible, and evidence-based access to psychedelics.

Intelligent Risk icon
Education
Through conferences, courses, events, and publishing, we are a hub for psychedelic education.
Policy Reform
We advocate for the dignity and rights of all people who use drugs, free from fear and stigma.
Passion and Perseverance icon
Harm Reduction
Harm reduction saves lives. Learn about how to reduce your risk or provide peer support through The Zendo Project.

Psychedelic Science 2023

June 19-23

Begin Your Journey

Curious about psychedelics?
MAPS is your trusted source for evidence-based information about psychedelic substances and integrated treatments

What every therapist needs to know.
MAPS is your trusted source for evidence-based information about psychedelic substances and integrated treatments

Be the Bridge
MAPS is your trusted source for evidence-based information about psychedelic substances and integrated treatments

First Responders & Medical Professionals
Read about our research; apply to be part of a clinical trial

Health Equity
Mental health is a human right.

Why MAPS?

History

Since 1986, MAPS has worked tirelessly to build and share the blueprint for ending psychedelic prohibition. This MAPS blueprint is being used throughout the world to take an evidence-based approach to psychedelic healing. As a nonprofit, MAPS has relied on the support of people like you to pursue our mission, build a movement, and change the way people think about, talk about, and consume psychedelics through research, education, and advocacy.

Values

Working to end psychedelic prohibition requires transparency and perseverance. Our work relies on the support of people from all backgrounds with all types of experience and contributions to share. Our approach is informed by our Seven Principles. We strive to embody an unwavering commitment to equity and compassion. Moreover, we are committed to a culture of curiosity and a long-term vision informed by research.

Impact

MAPS has incubated what will likely be the first psychedelic-assisted therapy to obtain government approval in the US. Thanks to our community of supporters and dedicated team, we have been able to spread this playbook widely, develop our Psychedelic Fundamentals online course, and host the largest gathering of the Psychedelic Renaissance. Ultimately, we aim to end drug prohibition everywhere and unlock the healing potential of psychedelics for all who seek their benefit.

Vision

We envision a world where psychedelics and marijuana are safely and legally available for beneficial uses—where research is governed by rigorous scientific evaluation of their risks and benefits. Our priority is public benefit, and our approach reflects this commitment to community over profit. Our work is intended to support the rights and dignity of all those who use these drugs free from fear and stigma.

MAPS is a nonprofit organization that provides public resources and leadership as we work together to create legalresponsibleevidencebased pathways to psychedelics.

Help Us Deliver Global Healing

Every dollar that MAPS has raised for psychedelic research and therapy has been donated by people like you. Your tax-deductible contributions are what allow MAPS to pursue the urgent and challenging work of psychedelic research, drug policy reform, public education, health equity, and harm reduction initiatives.

Donation Frequency
Donation Amount
< back

Contact Information

Contact information

Thanks for your contribution to MAPS!

Your tax-deductible contribution supports psychedelic science research, drug policy reform, public education, harm reduction, peer support, and our general operations.